<DOC>
	<DOCNO>NCT00002341</DOCNO>
	<brief_summary>To provide maintenance treatment itraconazole solution patient clinical responder ITR-USA-94 protocol , even subsequently relapse .</brief_summary>
	<brief_title>A Study Treatments Fungal Infections Mouth Throat HIV-Infected Patients Who Have Had Success With Itraconazole But Not With Fluconazole</brief_title>
	<detailed_description>Patients respond therapy protocol FDA 236B receive maintenance itraconazole oral solution 6 month .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Candidiasis</mesh_term>
	<mesh_term>Candidiasis , Oral</mesh_term>
	<mesh_term>Itraconazole</mesh_term>
	<mesh_term>Hydroxyitraconazole</mesh_term>
	<mesh_term>Fluconazole</mesh_term>
	<criteria>Inclusion Criteria Patients must : Met criterion clinical response protocol FDA 236B residual visible lesion oropharyngeal candidiasis upon completion study OR initial response protocol FDA 236B subsequent relapse retreatment itraconazole solution therapy . Life expectancy least 3 month . Exclusion Criteria Coexisting Condition : Patients follow symptoms condition exclude : Underlying clinical condition would preclude completion study place subject significant risk . Judged unreliable respect physician 's directive . Concurrent Medication : Excluded : Rifampin . Rifabutin . Phenobarbital . Phenytoin . Carbamazepine . Terfenadine . Astemizole . Systemic antifungal . Patients follow prior condition exclude : Previously document disseminated candidiasis . Previous clinically significant adverse event treatment itraconazole oral solution , unless clearly attributable intercurrent illness condition . History significant hepatic abnormality clinical evidence significant hepatic disease within 2 month prior study entry . Prior Medication : Excluded : Any investigational drug ( itraconazole solution ) within 1 month prior study entry .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 1996</verification_date>
	<keyword>Itraconazole</keyword>
	<keyword>Acquired Immunodeficiency Syndrome</keyword>
	<keyword>AIDS-Related Complex</keyword>
	<keyword>Candidiasis , Oral</keyword>
</DOC>